Previous Close | 24.68 |
Open | 24.83 |
Bid | 21.78 x 800 |
Ask | 24.82 x 900 |
Day's Range | 24.43 - 24.99 |
52 Week Range | 23.07 - 57.65 |
Volume | |
Avg. Volume | 2,112,441 |
Market Cap | 21.602B |
Beta (5Y Monthly) | 0.84 |
PE Ratio (TTM) | 6.73 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.96 (3.88%) |
Ex-Dividend Date | May 12, 2022 |
1y Target Est | N/A |
Philips Image Guided Therapy System – Azurion Philips intravascular ultrasound (IVUS) Philips iFR May 16, 2022 Co-registration of real-time intravascular ultrasound and/or iFR physiological assessment data onto motion-compensated angiograms aids percutaneous coronary intervention (PCI) procedure planning, quantitative lesion measurement, stent choice and sizing, and therapy assessmentReduced need for contrast media enables broader access to PCI for patients at risk of acute kidney injuryUltra-lo
Philips EchoNavigator 4.0 May 16, 2022 EchoNavigator 4.0 empowers heart teams with greater control of live fusion imaging plus new anatomical modeling and transseptal puncture guidance during minimally-invasive proceduresSeamless integration and communication between Philips Ultrasound System - EPIQ CVxi - and Philips Image Guided Therapy System - Azurion - supports efficient fusion-imaging workflow for minimally-invasive treatment of structural heart disease Amsterdam, the Netherlands – Royal P
May 10, 2022 Philips’ Supervisory Board takes note of the advisory vote on the 2021 Remuneration Report, will continue to engage with shareholders and consider the feedback received in its next remuneration report Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announced that today’s Annual General Meeting of Shareholders (2022 AGM) has approved the company’s proposed dividend of EUR 0.85 per share over 2021, and appointed Mrs. Herna Verhagen and Mr. Sanjay Poonen and re-appoin